InvestorsHub Logo
icon url

boi568

03/05/24 8:44 PM

#453515 RE: Steady_T #453507

It all seems to depend on whether the FDA would accept any of the possible Anavex biomarkers as acceptable. Otherwise, as you say, the company would be relying on the ADAS-Cog and the CDR-SB measures.

It's good to have Kun Jin onboard in this circumstance.